Authors: ANDRIOLE GL WALSH PC EPSTEIN JI HUDSON P ROMAS N COOK TJ WALDSTREICHER J GUESS H

Citation: Gl. Andriole et al., TREATMENT WITH FINASTERIDE PRESERVES THE USEFULNESS OF PSA IN PROSTATE-CANCER (CAP) DETECTION, The Journal of urology, 159(5), 1998, pp. 277-277

Authors: STONER E GUESS H

Citation: E. Stoner et H. Guess, TREATMENT OF BENIGN PROSTATIC HYPERPLASIA WITH 5-ALPHA-REDUCTASE INHIBITORS, The Endocrinologist, 5(2), 1995, pp. 140-146

Authors: STONER E GUESS H

Citation: E. Stoner et H. Guess, THE EFFECT OF FINASTERIDE ON PROSTATE VOLUME, URINARY FLOW-RATE AND SYMPTOM SCORE IN MEN WITH BENIGN PROSTATIC HYPERPLASIA - COMMENT, Australian and New Zealand journal of surgery, 65(5), 1995, pp. 360-360

Authors: GORMLEY GJ NG J COOK T STONER E GUESS H WALSH R

Citation: Gj. Gormley et al., EFFECT OF FINASTERIDE ON PROSTATE-SPECIFIC ANTIGEN DENSITY, Urology, 43(1), 1994, pp. 53-58

Authors: SANTANELLO NC GUESS H HEYSE JF

Citation: Nc. Santanello et al., CAPTOPRIL, ENALAPRIL, AND QUALITY-OF-LIFE, The New England journal of medicine, 329(7), 1993, pp. 505-505